Background & Aims Pregnant women with inflammatory bowel disease (IBD) may require
biologic or thiopurine therapy to control disease activity. Lack of safety data has led to …

Background Inflammatory bowel disease (IBD) affects people during their prime
reproductive years. The thiopurines (6-mercaptopurine and azathioprine), commonly used …

Maintaining remission of inflammatory bowel disease (IBD) during pregnancy is critical for
positive pregnancy outcomes. Conflicting data exist regarding the association between …

Background & Aims Most data on the safety of thiopurine therapy for inflammatory bowel
disease (IBD) during pregnancy come from retrospective studies, which makes it difficult to …

Background and aims Few studies have been conducted addressing the safety of thiopurine
treatment in pregnant women with inflammatory bowel disease (IBD). The aim of this study …

OBJECTIVES: The safety of thiopurines and anti-tumor necrosis factor-α (TNF-α) drugs
during pregnancy remains controversial, as the experience with these drugs in this situation …

OBJECTIVES: Immunomodulators are used as maintenance treatment of inflammatory
bowel disease (IBD). Data regarding their possible effects in the course of pregnancy when …

Background Ulcerative colitis (UC) and Crohn's disease (CD) have been associated with
increased risks of adverse birth outcomes. Disease activity and drug exposure may …

Objective The aim of this study was to describe the long-term health outcomes of children
born to mothers with inflammatory bowel disease (IBD) and to assess the impact of maternal …

Background Inflammatory bowel disease (IBD) affects a substantial number of female
patients in their reproductive years. Therefore, many physicians face the dilemma whether …